{"schema_version":"secwatch.filing_event.v1","accession":"0001625101-21-000050","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2021-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.371207+00:00","generated_at":"2026-06-28T22:37:44.244009+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Pulse Biosciences appoints Laureen DeBuono to board, Kenneth Clark resigns","bullets":["Kenneth Clark resigned from Board on Oct 4; holds vested options for 150,574 shares at $10.66-$23.08.","Laureen DeBuono elected to Board; will serve on Audit Committee and chair Nominating Committee.","DeBuono received initial grant of 32,500 stock options; annual retainers: $40k board, $10k Audit, $10k Nominating Chair.","Chief Strategy Officer Mr. Levinson designated as an executive officer under the Exchange Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001625101-21-000050","json":"https://secwatch.observer/filing/0001625101-21-000050.json","markdown":"https://secwatch.observer/filing/0001625101-21-000050.md","text":"https://secwatch.observer/filing/0001625101-21-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/plse-20211004x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:37:44.244009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d3333eb9cd","claim":"Laureen DeBuono was elected as Director at PULSE BIOSCIENCES, INC..","evidence_excerpt":"On October 4, 2021, the Board elected Laureen DeBuono to the Board, effective immediately, to fill the vacancy on the Board resulting from Mr. Clark’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e05dde8da8","claim":"Kenneth A. Clark resigned as Director at PULSE BIOSCIENCES, INC..","evidence_excerpt":"On October 4, 2021, Kenneth A. Clark resigned from the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) and from all committees of the Board for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}